Delivery Order SPE2DB22D3016-SPE2DB24FBBZ4
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,838.56 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,734,299 units of the prescription medication Vyvanse (60mg capsules) over a period ending on May 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, serving as the primary vehicle for the company to...
This federal contract award is for the delivery of 4,565,586,265 units of the prescription medication Vyvanse 30mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,764.74, was awarded to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. This is a firm fixed-price delivery order contract, with an ultimate completion date of August 27, 2024. The contract was not set aside for a specific business type....
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
The Defense Logistics Agency (DLA) has awarded a $9,524.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,333,941 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
This federal contract award, valued at $4,108.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,869 units of the prescription medication Vyvanse 50 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of May 8, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,997,140 units of Vyvanse 40 mg capsules. The $1,393.44 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical supplies to military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a $3,274.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,565,442,423 units of the 20 mg Vyvanse capsule medication. The contract has an ultimate completion date of August 14, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies, including an Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $4,082.52 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,752,660 units of the drug Vyvanse 10 mg capsules. This contract has an ultimate completion date of September 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $15,115.44 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,699,665 units of Vyvanse 50 mg capsules. This contract has a completion date of September 6, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including a $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide 4,565,128,796 units of the prescription drug Vyvanse 20 mg capsules. The $6,573.70 firm-fixed-price contract has a completion date of July 12, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...